U.S. markets closed

Axalta Coating Systems Ltd. (AXTA)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
25.03-0.59 (-2.30%)
At close: 04:00PM EDT
25.03 0.00 (0.00%)
After hours: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected


Previous Close25.62
Bid25.03 x 800
Ask25.11 x 1400
Day's Range25.00 - 25.51
52 Week Range21.44 - 34.12
Avg. Volume2,397,156
Market Cap5.52B
Beta (5Y Monthly)1.35
PE Ratio (TTM)27.51
EPS (TTM)0.91
Earnings DateOct 24, 2022 - Oct 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est30.37
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-21% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for AXTA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Axalta Coating Systems Ltd.
    Analyst Report: DaVita Inc.DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
    Fair Value
    Economic Moat
    8 days agoMorningstar
View more
  • Motley Fool

    Axalta Coating Systems (AXTA) Q2 2022 Earnings Call Transcript

    This is Chris Evans, VP of investor relations. Both our prepared remarks and discussion today may contain forward-looking statements, reflecting the company's current view of future events and their potential effect on Axalta's operating and financial performance. Please note that the company is under no obligation to provide updates to these forward-looking statements.

  • Zacks

    Axalta Coating Systems (AXTA) Surpasses Q2 Earnings Estimates

    Axalta Coating Systems (AXTA) delivered earnings and revenue surprises of 2.50% and 1.28%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    Axalta Releases Second Quarter 2022 Results

    Record pricing and strong volume growth drove a solid quarterly performance above mid-point of expectationsGLEN MILLS, Pa., July 26, 2022 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA) (“Axalta”), a leading global coatings company, announced its financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Highlights: Net sales increased 9.6% year-over-year (14.5% ex FX) led by record pricing and solid volume growth; Mobility Coatings delivered significant above-